Loading articles...
Strategies Emerge to Mitigate Post-GLP-1 Weight Regain
Weight regain following cessation of GLP-1 receptor agonist therapy presents a clinical challenge; emerging strategies focus on sustained pharmacological intervention and lifestyle modification.
PROTEUS Trial: Neoadjuvant Apalutamide Plus ADT in High-Risk Prostate Cancer
The PROTEUS trial investigated neoadjuvant apalutamide plus ADT for high-risk localised prostate cancer, showing improved pathologic complete response rates.
Alcohol's Role in Healthy Lifestyle: A Reassessment
Recent GBD data and related studies prompt a re-evaluation of alcohol's place in a healthy lifestyle, particularly concerning mental health and longevity.
Zurich Heart Surgery Scandal: Device Safety Alert Issued
A safety alert has been issued regarding cardiac devices used in Zurich, prompting concerns about patient outcomes and regulatory oversight.
Normal Flatus Frequency: Up to 25 Episodes Daily Considered Typical
Understanding normal flatus frequency is essential for distinguishing physiological gas from symptoms of gastrointestinal pathology. Up to 25 episodes per day is typical.
Semaglutide Not Linked to Increased AMD Risk in New Analysis
A recent study found no statistically significant association between semaglutide use and the incidence of age-related macular degeneration (AMD).
Semaglutide Accepted in Scotland for CV Risk Reduction in T2D
Semaglutide has been accepted in Scotland for reducing cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease.
Doppler Measures Identify Brain Injury Risk in Fetal Growth Restriction
Doppler ultrasound assessment of fetal circulation identifies fetuses with growth restriction at increased risk of brain injury.
CGRP Monoclonal Antibodies for Migraine Linked to Fracture Risk
New data indicate CGRP monoclonal antibodies, used for migraine prevention, may be associated with an increased risk of bone fractures. Clinicians should consider this risk.
AI Enhances Oxygen Therapy Titration, Reduces Hypoxia Duration
Artificial intelligence algorithms are demonstrating efficacy in automating oxygen therapy titration, potentially reducing episodes of hypoxia and hyperoxia.